Clinical and Economic Benefits of Antimicrobial Stewardship Programs in Hemodialysis Facilities
Open Access
- 23 August 2018
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 13 (9) , 1389-1397
Abstract
Background and objectives: Infections caused by multidrug-resistant organisms and Clostridium difficile are associated with substantial morbidity and mortality as well as excess costs. Antimicrobial exposure is the leading cause for these infections. Approximately 30% of antimicrobial doses administered in outpatient hemodialysis facilities are considered unnecessary. Implementing an antimicrobial stewardship program in outpatient hemodialysis facilities aimed at improving prescribing practices would have important clinical and economic benefits. Design, setting, participants, & measurements: We developed a decision analytic model of antimicrobial use on the clinical and economic consequences of implementing a nationwide antimicrobial stewardship program in outpatient dialysis facilities. The main outcomes were total antimicrobial use, infections caused by multidrug-resistant organisms and C. difficile, infection-related mortality, and total costs. The analysis considered all patients on outpatient hemodialysis in the United States. The value of implementing antimicrobial stewardship programs, assuming a 20% decrease in unnecessary antimicrobial doses, was calculated as the incremental differences in clinical end points and cost outcomes. Event probabilities, antimicrobial regimens, and health care costs were informed by publicly available sources. Results: On a national level, implementation of antimicrobial stewardship programs was predicted to result in 2182 fewer infections caused by multidrug-resistant organisms and C. difficile (4.8% reduction), 629 fewer infection-related deaths (4.6% reduction), and a cost savings of $106,893,517 (5.0% reduction) per year. The model was most sensitive to clinical parameters as opposed to antimicrobial costs. Conclusions: The model suggests that implementation of antimicrobial stewardship programs in outpatient dialysis facilities would result in substantial reductions in infections caused by multidrug-resistant organisms and C. difficile, infection-related deaths, and costs.Keywords
This publication has 31 references indexed in Scilit:
- Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremiaBMC Infectious Diseases, 2011
- Attributable Costs of Enterococcal Bloodstream Infections in a Nonsurgical Hospital CohortInfection Control & Hospital Epidemiology, 2010
- Clostridium difficile Infections in Outpatient Dialysis CohortInfection Control & Hospital Epidemiology, 2010
- Antibiotic Use in Neonatal Intensive Care Units and Adherence With Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial ResistanceThe Pediatric Infectious Disease Journal, 2009
- Impact of an Antimicrobial Utilization Program on Antimicrobial Use at a Large Teaching Hospital A Randomized Controlled TrialInfection Control & Hospital Epidemiology, 2009
- Multidrug-Resistant Gram-Negative Bacteria among Patients Who Require Chronic HemodialysisClinical Journal of the American Society of Nephrology, 2008
- Short- and Long-Term Attributable Costs of Clostridium difficile-Associated Disease in Nonsurgical InpatientsClinical Infectious Diseases, 2008
- Use of Vancomycin or First-Generation Cephalosporins for the Treatment of Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus BacteremiaClinical Infectious Diseases, 2007
- Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial StewardshipClinical Infectious Diseases, 2007
- Clinical Outcomes and Costs Due toStaphylococcus aureusBacteremia Among Patients Receiving Long-Term HemodialysisInfection Control & Hospital Epidemiology, 2005